Riskpilot← Back to searchSign inGet full accessLinvatec Conmed Sweden AB
ABActiveOrg 5565616520Datavägen 10 DWholesale of pharmaceutical and medical goods · NACE 4646Est. 199820-49 employees
Revenue 2024
SEK 130,5M
+3% vs 2023
EBITDA margin
8.1%
+21% vs 2023
Equity ratio
62.1%
Financial strength
Net profit 2024
SEK 8,2M
+23% vs 2023
| Revenue | SEK 130,5M | +3% |
| EBITDA | SEK 10,5M | +21% |
| Net profit | SEK 8,2M | +23% |
| Total assets | SEK 42,9M | +7% |
| Equity | SEK 26,6M | +5% |
| Employees | — | — |
Legal name
Linvatec Conmed Sweden AB
Org number
5565616520
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6 november 1998
Share capital
SEK 6 020 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med suppleanten Firman tecknas i förening av suppleanten Pelletier, Johonna Marie Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolagets verksamhet ska vara att vara totalleverantör inom operationsutrustning och endoskopi samt därmed förenlig verksamhet.
Address
Datavägen 10 D
Email
infose@linvatec.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 78 020 | 102 711 | 114 818 | 126 612 | 130 513 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 629 | 5 109 | 7 476 | 8 671 | 10 517 |
| Depreciation & amort. | −73 | −106 | −157 | −324 | −269 |
| EBIT | 6 556 | 5 003 | 7 319 | 8 347 | 10 248 |
| Net financials | −1 | −27 | 6 | 195 | 162 |
| Profit before tax | 6 555 | 4 976 | 7 326 | 8 542 | 10 410 |
| Tax | −1 451 | −1 100 | −1 590 | −1 865 | −2 216 |
| Net profit | 5 104 | 3 876 | 5 736 | 6 677 | 8 194 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 33 271 | 37 888 | 41 158 | 39 965 | 42 942 |
| Equity | 17 164 | 13 040 | 18 776 | 25 454 | 26 647 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16 107 | 24 848 | 22 381 | 14 511 | 16 295 |
| Total debt | 16 107 | 24 848 | 22 381 | 14 511 | 16 295 |
EBITDA margin
8.1%
This company
15.8%
Market median
-49% vs market
20202024
Equity ratio
62.1%
This company
38.2%
Market median
+63% vs market
20202024
Return on equity
30.8%
This company
18.4%
Market median
+67% vs market
20202024
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20202024
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
RL | Audit | 2022 |
JM External Signatory | External Signatory | 2022 |
AC Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
XP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TM External Signatory | External Signatory | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (4) | ||
| Chairman | 2023 – 2023 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CONMED DENMARK APS
Linvatec Conmed Sweden AB (this company)Board members of Linvatec Conmed Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rickard Lars Magnus Norinder | Audit | 0 companies |
| Terence Matthew Berge | External Signatory | 0 companies |
| Johonna Marie Pelletier | External Signatory | 0 companies |
| Anders Christer Malmström | Authorized Recipient of Service | 0 companies |
| Xavier Planas de Maruri | Chief Executive Officer | 0 companies |
| Daniel Sall Jonas | Chairman | 0 companies |
| Patrick Joseph Beyer | Board of Directors | 0 companies |
| Heather Lynn Cohen | Chairman | 0 companies |
| Tomé Manuel de Sousa | Board of Directors | 0 companies |
| Stéphane Epinette | Chairman | 0 companies |
| Lars Patric Eriksson | Deputy Board Member | 0 companies |